Hartmut J Ehrlich
About
Hartmut J Ehrlich is from Paris, Île-de-France, France. Hartmut is currently Chief Executive Officer at Abivax, located in Paris, Île-de-France, France.
Hartmut J Ehrlich's contact information is available for free on finalscout.com, a web-based professional networking database with more than 500 million business contacts and 200 million company profiles.
Hartmut J Ehrlich's current jobs
Creation of Abivax and entrepreneurial leadership of the company; Establishing preclinical and clinical programs for lead product candidates that target the immune system to treat inflammatory and viral diseases as well as cancer; Driving Abivax ongoing clinical trials with its lead molecules ABX464 (Phase 2b in ulcerative colitis, Phase 2a in rheumatoid arthritis, Phase 2b in Crohn's disease and Phase 2b/3 in COVID-19) and ABX196 (Phase 1/2 in HCC); Focus on modulation of RNA Biogenesis as key technology platform; Abivax' listing in 2015 with € 57.7m, the largest amount ever raised by a French biotech company at Euronext in Paris.